Clinical pharmacology of amantadine and derivatives
Amantadine has a definite although minor place in the clinical management of parkinsonism. It is simple to administer, well tolerated by patients, with rapid if usually minor to moderate benefit rather than dramatic response, and with few serious adverse effects.
KeywordsHerpes Zoster Anticholinergic Drug Methyl Amine Minor Place Amantadine Hydrochloride
Unable to display preview. Download preview PDF.
- Greenburg J (1971) Treatment of parkinsonism with amantadine hydrochloride. Pennsylv Med 74: 54Google Scholar
- Kelly JT, Abazzahab FS (1971) The antiparkinsonian properties of amantadine in drug-induced parkinsonism. J Clin Pharmacol 11: 211Google Scholar
- McEvoy JP (1987) A double-blind crossover comparison of antiparkinsonian drug therapy: amantadine versus anticholinergics in 90 normal volunteers, with an emphasis on differential effects on memory function. J Clin Psychiatr 48 [Suppl]: 20–23Google Scholar
- Völler G (1972) Zur Therapie des Parkinson-Syndroms mit Amantadin. Munch Med Wochenschr 14: 1066Google Scholar
- Webster DD, Sawjer GT (1984) The combined use of amantadine HCI and levodopa/carbidopa in Parkinson’s disease. Curr Ther Res 35: 1010–1013Google Scholar